🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Ph Positive ALL

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL NCT06481228NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: CAR-T cells, Venetoclax, Olverembatinib A Multicenter Study of CAR-T Cells in Primary Ph+All NCT07252336Phase 21 site📍 Hangzhou Zhejiang University · Tests: CD19 CAR-T cells Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia NCT07040982Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Asciminib, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Echocardiography Test Newly-diagnosed Pediatric Ph-positive B-ALL Protocol NCT07152041Phase 324 sites📍 Hefei📍 Chongqing📍 Fuzhou Institute of Hematology & Blood Diseases Hospital, China · Tests: olverembatinib Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia NCT03263572Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Cytarabine, Methotrexate, Ponatinib Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML NCT06757855Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Olverembatinib, Venetoclax, Azacitidine A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany NCT07549516n/a69 sites📍 Baden-Baden📍 Heidenheim📍 Schwäbisch Hall Novartis Pharmaceuticals CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT NCT07441291Phase 31 site📍 Beijing Peking University People's Hospital · Tests: CAR-T, DLI Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL NCT05495035Phase 14 sites📍 Hefei📍 Jinan📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Olverembatinib, APG-2575, Dexamethasone ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML NCT03595917Phase 14 sites📍 Chicago📍 Boston📍 Boston Marlise Luskin, MD · Tests: ABL001, Dasatinib, Prednisone, Blinatumomab A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) NCT06051409Phase 390 sites📍 Birmingham📍 Duarte📍 Los Angeles Ascentage Pharma Group Inc. · Tests: Olverembatinib, Investigator's choice of TKI Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL NCT06754267Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: Venetoclax, Olverembatinib, Predinisone EWALL-PH OBSERVARTORY 2022 NCT07684131n/a23 sites📍 Amiens📍 Angers📍 Bayonne Versailles Hospital Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers NCT03589729Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cladribine, Cytarabine, Dexrazoxane Hydrochloride, Gemtuzumab Ozogamicin, Idarubicin Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP NCT07354074Phase 234 sites📍 New Brunswick📍 New York📍 Cincinnati Novartis Pharmaceuticals · Tests: Asciminib single agent A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL NCT06220487Phase 21 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Prednisone, Olverembatinib, Blinatumomab, Chidamide A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs NCT03459534Phase 318 sites📍 Barnaul📍 Kirov📍 Moscow Il-Yang Pharm. Co., Ltd. · Tests: Radotinib HCl Ph 2 Elacestrant in ER Positive Uterine Sarcomas NCT07467772Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Elacestrant Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL NCT07250087Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Asciminib A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer NCT07227831NA8 sites📍 Bay City📍 Clarkston📍 Detroit Barbara Ann Karmanos Cancer Institute · Tests: TheraBionic P1 Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC NCT05918328Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Albumin paclitaxel+trastuzumab+pyrrolitinib, Docetaxel+Carboplatin+trastuzumab+Parstuzumab Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL NCT07433400n/a1 site📍 Pierre-Bénite Group for Research in Adult Acute Lymphoblastic Leukemia Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib NCT01746836Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Laboratory Biomarker Analysis, Ponatinib Hydrochloride, Quality-of-Life Assessment Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia NCT04925479Phase 1, Phase 239 sites📍 Indianapolis📍 Boston📍 Jackson Novartis Pharmaceuticals · Tests: Asciminib Pediatric formulation group, Asciminib Adult formulation group Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL NCT04260022Phase 19 sites📍 Birmingham📍 Duarte📍 Atlanta Ascentage Pharma Group Inc. · Tests: Ascentage Pharma HQP1351 bioavailable inhibitor, Blinatumomab Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL NCT07493161NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Olverembatinib, Venetoclax, Blinatumomab, Chemotherapy Backbone Regimens, Allogeneic Hematopoietic Stem Cell Transplant… Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT NCT06061094Phase 285 sites📍 Aachen📍 Aschaffenburg📍 Augsburg Goethe University · Tests: Imatinib, Ponatinib, Blinatumomab, Indication for stem cell transplantation Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma NCT07224100Phase 21 site📍 Seattle University of Washington · Tests: Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim, Pegfilgrastim Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia NCT06308588Phase 1, Phase 22 sites📍 The Bronx📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Asciminib A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) NCT06124157Phase 2161 sites📍 Birmingham📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy